awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37594373-439BEABB-2A4E-40F6-B519-6323D724BAF6
Q37594373-439BEABB-2A4E-40F6-B519-6323D724BAF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37594373-439BEABB-2A4E-40F6-B519-6323D724BAF6
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.
P2860
Q37594373-439BEABB-2A4E-40F6-B519-6323D724BAF6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37594373-439BEABB-2A4E-40F6-B519-6323D724BAF6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4aec02da6dc41c0fb05f576167d7b16ac99e979b
P2860
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy.